Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report)’s share price was up 3.3% on Wednesday . The company traded as high as $5.30 and last traded at $5.30. Approximately 16,659 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 205,918 shares. The stock had previously closed […]
iCAD (NASDAQ:ICAD – Get Free Report) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, institutional ownership, risk and analyst recommendations. Valuation & Earnings […]
iCAD (NASDAQ:ICAD – Get Free Report) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Insider & Institutional […]
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ – Get Free Report) and Pro-Dex (NASDAQ:PDEX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Valuation & Earnings This table […]
In order to provide an overview for busy in-house counsel and compliance professionals, we summarize below some of the most important SEC enforcement developments from the past month.